Efficacy of Temocillin in Urinary Tract Infection Due to ESBL Producing and AmpC Hyperproducing Enterobacteriaceae
Phase of Trial: Phase IV
Latest Information Update: 02 Dec 2016
At a glance
- Drugs Temocillin (Primary)
- Indications Urinary tract infections
- Focus Therapeutic Use
- 29 Nov 2016 Planned primary completion date changed from 1 Feb 2017 to 1 Apr 2017.
- 29 Nov 2016 Status changed from not yet recruiting to recruiting.
- 22 Feb 2016 New trial record